The brain needs cleaning to stay healthy

When neurons die, their debris need to be quickly removed in order for the surrounding brain tissue to continue to function properly. Elimination of the neuron corpses, in a process called phagocytosis, is carried out by highly specialized cells in the brain called microglia. These small cells have many ramifications that are in constant motion and are specially equipped to detect and destroy any foreign element, including dead neurons. Or so it was thought until now.

This study, publishing May 26, 2016 in PLOS Biology, investigates, for the first time, the process of neuronal death and microglial phagocytosis in the diseased brain. To this end, scientists collected brain samples from epilepsy patients at University Hospital of Cruces and from epileptic mice.

It is known that during epilepsy-associated seizures, neurons die. However, contrary to what happens in the healthy brain, during epilepsy, microglia seem to be "blind" and unable to find the dead neurons and to destroy them. Their behavior is abnormal. Therefore, dead neurons cannot be eliminated and accumulate, spreading the damage to neighboring neurons and triggering an inflammatory response that worsens the brain injury.

This discovery opens a new avenue to explore therapies that could alleviate the effects of brain diseases. In fact, the research group that undertook these studies is currently developing drugs, hoping to boost this cleaning process -phagocytosis- and help in the treatment of epilepsy.

The study was led by Dr. Amanda Sierra, director of the Laboratory of Glial Cell Biology at the Achucarro Basque Center for Neuroscience. The experimental work was mainly carried out by Oihane Abiega, Sol Beccari, and Irune Diaz Aparicio. Other scientists from Achucarro and UPV/EHU, including Juan Manuel Encinas, Jorge Valero, Victor Sanchez-Zafra, and Inaki Paris, also contributed to the study

This international research effort was coordinated from the Basque Country, and scientists from CIC bioGUNE (Spain), the University of Bordeaux (France), the University of Southampton (UK), Laval University (Canada), and Baylor College of Medicine (USA) also took part.